Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1785 (LINC01785) is a human long non-coding RNA (lncRNA), located on chromosome 19, and annotated in major public databases (GeneCards, Ensembl, HGNC)[1][3][7]. LINC01785 belongs to the class of lncRNAs, which are transcripts longer than 200 nucleotides that are not translated into proteins. lncRNAs participate in a variety of cellular processes, including chromatin remodeling, gene expression regulation, and epigenetic modification[9][2]. Many lncRNAs have been implicated in cellular differentiation, development, and disease (especially cancer)[9][2]. However, as of now there are no published functional studies, disease associations, drug interactions, or biomarker data specifically for LINC01785, differentiating it from better-characterized lncRNAs. lncRNAs as a class have been recognized as potential prognostic tools, cancer drivers, or therapeutic targets, but there is no evidence that LINC01785 individually is considered in these roles[9][3].
Not applicable; no drugs currently target this RNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1785 (LINC01785).